Newsfeeds Archive - Spark Newswire

2 minute read

This Analyst Is Bullish On Biohaven’s Approach in Neuro-Psych Space

February 16, 2:58 PM

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset Kv7-7000's Phase 3 trial this year, reducing late-stage risks.

BHVN

2 minute read

UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst

By Vandana Singh

February 6, 3:19 PM

UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.

ABBV

1 minute read

Analyst Ratings

Mizuho Downgrades Karuna Therapeutics: Here’s What You Need To Know

By Benzinga Insights

January 26, 1:00 PM

Mizuho downgraded its rating of Karuna Therapeutics (NASDAQ:KRTX) to Neutral with a price target of $330.00, changing its…

KRTX

2 minute read

Uncategorized

5 Biotech Stocks That Should Be On Investors’ Radar As JPMorgan Healthcare Conference Gets Underway Monday

By Shanthi Rexaline

January 8, 7:04 AM

The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting.

ABBV

2 minute read

Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday

By Avi Kapoor

December 28, 9:35 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

BALL

2 minute read

Bristol-Myers’ Acquisition Of Karuna Therapeutics Paves Way For Aggressive Global Marketing Of KarXT: Analyst

By Nabaparna Bhattacharya

December 26, 3:02 PM

H.C.

BMY

2 minute read

Cognizant Technology Solutions To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday

By Avi Kapoor

December 26, 9:03 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

ALVR

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

December 25, 1:30 PM

Gainers Jin Medical International (NASDAQ:ZJYL) shares moved upwards by 94.4% to $137.0 during Monday’s regular session. The market…

ALVR

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

December 25, 9:05 AM

Gainers Karuna Therapeutics (NASDAQ:KRTX) shares increased by 47.4% to $317.1 during Monday’s pre-market session. The company’s market cap…

ALVR

4 minute read

Dow Edges Lower; Nike Sales Miss Estimates

By Avi Kapoor

December 22, 3:47 PM

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Friday. The Dow traded down 0.05% to 37,385.32 while the NASDAQ rose 0.12% to 14,982.36. The S&P 500 also rose, gaining, 0.15% to 4,753.64.

ADN